SEC Comment Letter for Alector, (ALEC) — Mar 17, 2026
Alector, Inc.
Date: March 17, 2026 · CIK: 0001653087 · Accession: 0000000000-26-002712
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294241
Letter
Re: Alector, Inc. Registration Statement on Form S-3 Filed March 12, 2026 File No. 333-294241 Dear Arnon Rosenthal Ph.D.:
March 17, 2026
Arnon Rosenthal, Ph.D. Chief Executive Officer Alector, Inc. 131 Oyster Point Blvd., Suite 600 South San Francisco, CA 94080
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Michael Coke, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 17, 2026 Arnon Rosenthal, Ph.D. Chief Executive Officer Alector, Inc. 131 Oyster Point Blvd., Suite 600 South San Francisco, CA 94080 Re: Alector, Inc. Registration Statement on Form S-3 Filed March 12, 2026 File No. 333-294241 Dear Arnon Rosenthal Ph.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Michael Coke, Esq. </TEXT> </DOCUMENT>